Stephanie Diaz | Manager of Investor Relations |
Brian Lian | President and CEO |
Greg Zante | CFO |
Steven Seedhouse | Raymond James |
Jay Olson | Oppenheimer |
Joon Lee | Truist Securities |
Andy Hsieh | William Blair |
Yale Jen | Laidlaw & Co |
Thomas Smith | Leerink Partners |
Justin Zelin | BTIG |
Dylan Dupuis | Roth MKM |
Welcome to the Viking Therapeutics Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this conference call is being recorded today, July 26, 2023.
I would now like to turn the conference over to Viking’s Manager of Investor Relations, Stephanie Diaz.